Dr. Daniel Tesfaye, MD

Dr. Tesfaye practices at Atlanta Neuro Care in Conyers, Georgia.

Dr. Tesfaye's NPI, 1023033065, was assigned on July 12, 2006. Dr. Tesfaye holds Georgia license 67614.

Dr. Tesfaye's primary practice is Atlanta Neuro Care, at 1368 Wellbrook Cir Ne Suite A Suite A, Conyers, GA 30012-3980. The practice phone is (770) 274-3378.

Dr. Tesfaye's primary practice is Atlanta Neuro Care in Conyers, Georgia. Dr. Tesfaye is also affiliated with Piedmont Rockdale. The medical group on file is Atlanta Neuro Care. Dmand AI also links Dr. Tesfaye to 2 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tesfaye practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tesfaye's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tesfaye is licensed in Georgia.

CMS data shows 888 Medicare services from Dr. Tesfaye across 15 procedure codes in 2024, for 261 Medicare patients. Medicare paid $87,563 for them. Every service was in an office.

CMS counts 261 Medicare patients who saw Dr. Tesfaye in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tesfaye's median patient age at 68, with 64% women.

In 2024, Dr. Tesfaye wrote 2,557 Medicare Part D claims for 455 patients. 88% of them were for generic drugs. CMS names the drug for 2,263 of them, across 52 drugs with 11 or more claims each, at $879,783 in total drug cost. In 2023, CMS named 1,913 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Tesfaye for performance year 2024, reported individually. Dr. Tesfaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tesfaye as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 866 general payments to Dr. Tesfaye from 60 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 99% of the total. UCB, Inc. paid the most, $2,034.